查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1995292

血液處理設備及耗材市場：按產品類型、技術、應用、最終用戶和分銷管道分類的全球市場預測，2026年至2032年

Blood Processing Devices & Consumables Market by Product Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年血液處理設備和耗材市場價值為 552.5 億美元，預計到 2026 年將成長至 587.9 億美元，複合年成長率為 7.22%，到 2032 年將達到 900.5 億美元。

主要市場統計數據
基準年 2025 552.5億美元
預計年份：2026年 587.9億美元
預測年份 2032 900.5億美元
複合年成長率 (%) 7.22%

對影響血液處理設備和耗材未來部署的臨床、技術、監管和營運趨勢進行全面分析。

血液處理設備和耗材的市場格局正在不斷演變，這受到臨床需求、技術創新和日益嚴格的監管要求的共同影響。醫療機構、檢查室管理人員和採購團隊正面臨著一個不斷變化的環境，設備效能、耗材品質和工作流程整合決定臨床可靠性和營運效率。本執行摘要概述了血液採集、分離、檢測和儲存流程決策者面臨的最重要主題促進因素和實際影響。

自動化、病原體控制創新和整合生命週期支援如何重新定義整體血液處理的採購重點和營運模式。

隨著自動化技術的成熟、病原體減少技術的進步以及數據驅動的品質保證日益融入工作流程，血液處理生態系統正經歷變革性的轉變。自動化處理平台正從試點階段走向高通量設施的主流部署，這改變了人工操作的作用，並重新定義了人員配置模式。隨著這些平台的擴展，關注點正從單一功能的效能轉向系統互通性和整個生命週期的總體擁有成本，催生了新的採購標準和對供應商服務的期望。

與關稅相關的供應鏈重組和採購彈性策略正在重塑採購、生產在地化和檢驗供應商多元化。

美國近期推出的關稅措施為製造商、經銷商和終端用戶帶來了新的考量，不僅影響直接成本，也影響供應鏈結構、籌資策略和供應商選擇。關稅帶來的價格壓力促使企業重新評估零件採購，盡可能實現在地化生產，並尋求供應商多元化以降低風險。雖然這些策略轉變短期內可能會增加複雜性，但從長遠來看，它們也將加速對本地生產和經認證的替代供應鏈的投資。

將產品分類、自動化範式、臨床應用、使用者畫像和通路與策略挑戰聯繫起來的詳細細分分析。

精細的細分分析揭示了產品類型、技術、應用、最終用戶和分銷管道中價值與風險的交集。在產品層面，耗材和醫療設備被區分開來。耗材包括抗凝血劑和添加劑、血袋和輸血器、過濾器和檢測套組，而醫療設備包括血漿分離機、離心機、病原體去除系統和儲存設備。每類產品都有其自身的監管路徑、耗材生命週期要求和使用者培訓要求，這些都會影響部署速度和服務模式。

對美洲、歐洲、中東、非洲和亞太地區的監管複雜性、基礎設施多樣性和分銷要求進行區域比較評估。

美洲、歐洲、中東、非洲和亞太地區的區域趨勢差異顯著，每個地區都有其獨特的監管環境、報銷體系和基礎設施，這些因素都會影響產品的採用路徑和供應商策略。在美洲，採購和臨床網路通常強調規模和整合，因此更傾向於採用能夠降低高容量醫療機構營運複雜性的整合解決方案和服務包。區域法規結構支援既定的檢驗流程，物流網路通常也便於醫療設備和耗材的集中配送。

在競爭格局和策略定位方面，我們強調有針對性的夥伴關係，以擴大我們的臨床檢驗、綜合服務網路和產品組合。

競爭格局主要由成熟的醫療設備製造商、專業耗材供應商以及提供創新自動化和診斷技術的新興科技公司組成。主要企業透過結合檢驗的臨床表現、完善的服務體係以及提供可互通的解決方案的能力來脫穎而出，這些解決方案能夠適應不同的實驗室資訊系統和醫院工作流程。策略夥伴關係和有針對性的收購已成為企業常用的策略，旨在彌補病原體清除、自動化和低溫運輸解決方案方面的能力缺口，同時拓展其在醫療設備和耗材領域的業務組合。

領導企業在平衡創新、供應鏈韌性和以客戶為中心的全生命週期支援方面面臨的實際營運和商業挑戰。

產業領導企業應優先考慮協作方式，在創新、供應鏈韌性和以使用者為中心的設計之間取得平衡。製造商需要投資可配置以適應各種處理能力的模組化自動化平台，同時確保與各種耗材相容，並減少客戶過渡過程中的摩擦。同時，對完善的售後服務、遠端診斷和軟體更新進行投資，將確保運作並維護長期的客戶關係。

透過結合關鍵相關人員的見解、監管映射和供應商概況，調查方法產生可操作和檢驗的市場資訊。

本研究整合了一手和二手資料，旨在建立基於證據的血液處理設備及耗材市場趨勢洞察。一手資料包括對臨床醫生、檢查室管理人員、採購負責人和技術負責人的結構化訪談，以及設備和耗材生命週期相關文件、臨床檢驗報告和監管備案文件。二手資料包括同行評審的臨床文獻、技術標準和政策文件，以了解產品性能聲明的背景及其影響因素。

透過整合強調檢驗的績效、高度適應性的服務模式和強大的採購系統的策略挑戰，我們確保長期的臨床和商業性成功。

總之，成功的新興參與企業和成熟企業都具備以下特點：經臨床檢驗性能、靈活且以服務為導向的經營模式以及穩健的供應鏈。自動化和病原體去除技術的進步雖然帶來了顯著的臨床和營運效益，但其應用需要可驗證的互通性、簡化的檢驗流程以及強大的售後支援。耗材的品質和相容性仍然是保障安全性和工作流程效率的關鍵，因此醫療設備製造商和耗材供應商之間的密切合作至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 血液處理設備及耗材市場：依產品類型分類

  • 消耗品
    • 抗凝血劑和添加劑
    • 血袋和血包
    • 篩選
    • 檢測套組
  • 裝置
    • 血液分離裝置
    • 離心機
    • 病原體去除系統
    • 儲存裝置

第9章 血液處理設備及耗材市場：依技術分類

  • 自動化處理
    • 全自動系統
    • 半自動系統
  • 手動處理

第10章 血液處理設備及耗材市場：依應用領域分類

  • 血液樣本
  • 組分分離
  • 診斷測試
  • 病原體去除
  • 倉儲/運輸

第11章 血液處理設備及耗材市場：依最終用戶分類

  • 血庫
  • 檢查室
  • 醫院和診所
  • 研究機構

第12章 血液處理設備及耗材市場：依通路分類

  • 直銷
  • 銷售代理
  • 電子商務

第13章 血液處理設備及耗材市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 血液處理設備及耗材市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 血液處理設備及耗材市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國血液處理設備與耗材市場

第17章：中國血液處理設備及耗材市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Baxter International
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi
  • Grifols, SA
  • Haemonetics Corporation
  • Immucor, Inc.
  • Macopharma SA
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • ThermoGenesis Holdings, Inc.
Product Code: MRR-AB49FC1AB774

The Blood Processing Devices & Consumables Market was valued at USD 55.25 billion in 2025 and is projected to grow to USD 58.79 billion in 2026, with a CAGR of 7.22%, reaching USD 90.05 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 55.25 billion
Estimated Year [2026] USD 58.79 billion
Forecast Year [2032] USD 90.05 billion
CAGR (%) 7.22%

Comprehensive framing of clinical, technological, regulatory, and operational dynamics shaping the future adoption of blood processing devices and consumables

The landscape for blood processing devices and consumables is evolving at the intersection of clinical need, technological innovation, and tightening regulatory expectations. Providers, laboratory directors, and procurement teams are navigating a shifting environment in which device performance, consumable quality, and workflow integration determine clinical reliability and operational efficiency. This executive summary synthesizes the thematic drivers and practical implications that matter most to decision-makers managing blood collection, separation, testing, and storage pathways.

Across clinical settings, demand signals are increasingly shaped by the need to balance throughput with safety. Innovations in automated processing and pathogen reduction aim to reduce variability and enhance safety, while consumable design advances seek to streamline handling and extend shelf life. At the same time, regulatory scrutiny and compliance frameworks are prompting closer alignment between manufacturers and end users, focusing on traceability, validation protocols, and postmarket surveillance. The convergence of these forces is leading organizations to prioritize interoperability, supply chain resilience, and lifecycle support during procurement and technology adoption.

This introduction frames the subsequent analysis by highlighting how technical performance, user-centric design, and policy drivers are creating a more integrated, quality-focused market. It also establishes the lens through which we examine segmentation, regional dynamics, tariff effects, and competitive positioning to surface actionable perspectives for stakeholders across clinical, laboratory, and research environments.

How automation, pathogen mitigation innovations, and integrated lifecycle support are redefining procurement priorities and operational models across clinical blood processing

The blood processing ecosystem is undergoing transformative shifts as automation matures, pathogen mitigation technologies advance, and data-driven quality assurance becomes increasingly embedded in workflows. Automated processing platforms are moving from experimental adoption to mainstream deployment in high-volume centers, which is altering the role of manual methods and redefining staffing models. As these platforms scale, attention shifts from single-function performance to system interoperability and lifecycle total cost of ownership, prompting new procurement criteria and vendor-service expectations.

Simultaneously, pathogen reduction systems and enhanced diagnostics are raising the bar for safety while stimulating demand for compatible consumables and validated processing protocols. These technological strides are complemented by improvements in storage and transport equipment that enable extended preservation windows and better temperature control, thereby expanding logistical options for blood centers and hospitals. The cumulative effect is a market that favors modular, adaptable solutions capable of integrating into diverse clinical pathways.

Operationally, end users are placing a premium on traceability, real-time quality metrics, and simplified user interfaces to lower training burdens and reduce handling errors. Distribution models are also evolving: direct sales relationships persist for complex instruments while distributors and e-commerce channels grow in importance for standardized consumables and replacement parts. Together, these shifts create a more connected, efficiency-oriented environment that rewards manufacturers who combine robust engineering with responsive support and validated clinical workflows.

Tariff-driven supply chain realignment and procurement resilience strategies that reshape sourcing, production localization, and validated supplier diversification

Recent tariff actions in the United States have introduced new considerations for manufacturers, distributors, and end users that extend beyond immediate cost implications to influence supply chain architecture, sourcing strategies, and vendor selection. Tariff-related pricing pressures incentivize companies to reassess component sourcing, regionalize production where feasible, and pursue supplier diversification to mitigate exposure. These strategic shifts can increase near-term complexity but also accelerate longer-term investments in local manufacturing and qualified alternative supply streams.

For manufacturers of both devices and consumables, tariffs influence decisions about where to base final assembly and how to structure supplier contracts to preserve margin while maintaining regulatory compliance. End users and procurement teams respond by expanding qualification processes to include additional suppliers and by negotiating service and warranty terms that account for longer lead times. Alongside procurement adjustments, there is a renewed emphasis on inventory management practices, including buffer stock policies and demand forecasting accuracy, to reduce risk of operational disruption during tariff-induced supply volatility.

Regulatory pathways and validation requirements can complicate rapid source substitutions, especially for critical consumables such as anticoagulants, filters, and blood bags. Consequently, organizations are balancing the trade-offs between cost containment and continuity of validated processes. In summary, the tariff environment is prompting a more deliberate, resilience-focused orientation across the value chain that emphasizes supplier redundancy, regional capacity, and rigorous change control mechanisms.

Deep segmentation analysis linking product classes, automation paradigms, clinical applications, user profiles, and distribution pathways to strategic imperatives

A nuanced segmentation view reveals where value and risk converge across product types, technologies, applications, end users, and distribution channels. Product-level differentiation separates consumables from devices, with consumables encompassing anticoagulants and additives, blood bags and sets, filters, and test kits, while devices cover apheresis machines, centrifuges, pathogen reduction systems, and storage equipment. Each product class carries distinct regulatory pathways, consumable lifecycle demands, and user training requirements that influence adoption cadence and service models.

Technology segmentation distinguishes automated processing from manual processing, highlighting the growing relevance of fully automated systems and semi-automated systems in high-throughput and resource-constrained settings respectively. This technological bifurcation drives varied spending patterns and integration needs across clinical environments, with automated solutions emphasizing software integration, data management, and vendor-supported maintenance, while manual processes depend more heavily on consumable standardization and user competency.

Application-based differences, spanning blood collection, component separation, diagnostic testing, pathogen reduction, and storage and transportation, create divergent performance metrics and validation checkpoints. End users such as blood banks, diagnostic laboratories, hospitals and clinics, and research institutes impose different priorities: supply continuity and regulatory compliance dominate in blood banks, diagnostic precision and throughput guide laboratory choices, clinical compatibility and bedside ergonomics matter in hospitals, and flexibility and experimental control are paramount in research settings. Distribution channels range from direct sales for complex instrumentation to distributors and e-commerce for consumables, shaping lead times, service models, and price transparency. These segmentation insights underscore the importance of aligning product development, commercial strategy, and post-sale support with the specific needs of each user cohort and technology class.

Comparative regional assessment of regulatory complexity, infrastructure variability, and distribution imperatives across the Americas, Europe Middle East and Africa, and Asia Pacific

Regional dynamics vary meaningfully across the Americas, Europe Middle East and Africa, and Asia Pacific, each presenting distinct regulatory, reimbursement, and infrastructure landscapes that influence adoption pathways and supplier strategies. In the Americas, procurement and clinical networks often emphasize scale and consolidation, which favors integrated solutions and service bundles that reduce operational complexity in high-volume centers. Regulatory frameworks in this region support established validation processes, and logistic networks generally facilitate centralized distribution for both devices and consumables.

Europe Middle East and Africa comprises a heterogeneous set of health systems where market access is influenced by stringent regulatory standards in some jurisdictions and constrained infrastructure in others. This diversity creates opportunities for adaptable product designs that can be configured for both resource-rich and resource-limited settings. Stakeholders operating in this region frequently must navigate cross-border regulatory harmonization, varied reimbursement rules, and the need for strong after-sales service to maintain clinical continuity.

Asia Pacific includes mature markets with advanced laboratory capabilities alongside rapidly developing healthcare systems that are scaling blood services. Local manufacturing investments and trade policies influence supply chain decisions, and end users often seek cost-effective solutions that do not compromise safety. Across the region, partnerships with regional distributors and strategic local service networks are essential to ensure uptime and regulatory compliance. Collectively, these regional insights inform how vendors should tailor market entry strategies, support models, and product configurations to align with local clinical and operational realities.

Competitive dynamics and strategic positioning that emphasize clinical validation, integrated service networks, and targeted partnerships to strengthen portfolio breadth

Competitive dynamics center on a mix of established medical device manufacturers, specialist consumable producers, and emerging technology entrants that offer novel automation or diagnostic capabilities. Leading players differentiate through a combination of validated clinical performance, comprehensive service ecosystems, and the ability to provide interoperable solutions that fit into diverse laboratory information systems and hospital workflows. Strategic partnerships and targeted acquisitions have been common tactics for firms seeking to broaden portfolios across both devices and consumables while closing capability gaps in pathogen reduction, automation, and cold chain solutions.

Mature companies typically leverage global service networks and extended warranties to support adoption in large-scale blood centers and hospital systems, whereas innovative challengers compete on modularity, lower upfront cost, and software-enabled workflow efficiencies. Distribution approaches also create competitive separation: organizations that maintain direct sales teams for complex instrument placements often embed long-term service agreements, while those that capitalize on distributor relationships or e-commerce channels emphasize scalability and rapid replenishment for consumables.

Market participants are increasingly investing in evidence generation, including clinical validations and real-world performance studies, to support procurement decisions and reimbursement discussions. This investment in clinical credibility, combined with demonstrable cost of ownership advantages and strong customer support, is central to winning both institutional contracts and long-term loyalty across clinical, laboratory, and research end users.

Actionable operational and commercial imperatives for leaders to balance innovation, supply chain resilience, and customer-centric lifecycle support

Industry leaders should prioritize a coordinated approach that balances innovation with supply chain resilience and user-centered design. Manufacturers must invest in modular automation platforms that can be configured across different throughput profiles, while ensuring compatibility with a broad range of consumables to reduce switching friction for customers. Parallel investments in robust post-sale service, remote diagnostics, and software updates will protect uptime and maintain long-term customer relationships.

Supply chain strategies should focus on qualified multi-sourcing, regional assembly capabilities, and inventory policies that reduce exposure to trade disruptions. Operational teams ought to formalize change control pathways that accelerate qualification of alternate suppliers without compromising validation requirements. Commercial teams should adapt contracting approaches to reflect total lifecycle costs rather than unit pricing alone, aligning incentives for service performance, consumable availability, and clinical outcomes.

Finally, leaders should engage proactively with regulators, standards bodies, and clinical stakeholders to shape pragmatic validation frameworks for new technologies, particularly pathogen reduction and highly automated systems. Investing in pragmatic evidence generation, clinician training programs, and interoperable data standards will accelerate adoption and de-risk procurement decisions for hospitals, blood banks, and laboratories.

Methodological framework blending primary stakeholder insights, regulatory mapping, and supplier profiling to produce pragmatic, verifiable market intelligence

This research synthesizes primary and secondary intelligence to develop an evidence-based view of the blood processing devices and consumables landscape. Primary inputs include structured interviews with clinicians, laboratory directors, procurement specialists, and technology leaders, complemented by device and consumable lifecycle documentation, clinical validation reports, and regulatory filings. Secondary inputs include peer-reviewed clinical literature, technical standards, and policy publications that contextualize product performance claims and adoption drivers.

The analytical approach combines qualitative thematic coding of stakeholder interviews with comparative product and supplier profiling to identify differentiators in design, usability, and service models. Regulatory pathways and validation requirements were mapped to product classes to clarify adoption barriers. Supply chain analysis considered component sourcing, manufacturing footprints, and distribution models, while risk assessments evaluated tariff impacts, lead time variability, and single-source dependencies. Throughout the methodology, emphasis was placed on triangulating multiple data sources to ensure robustness and to surface practical implications for procurement, R&D, and commercial strategy.

Synthesis of strategic imperatives emphasizing validated performance, adaptable service models, and resilient sourcing to secure long-term clinical and commercial success

The overarching conclusion is that successful entrants and incumbents will be those who combine validated clinical performance with adaptable, service-oriented business models and resilient supply chains. Technological advances in automation and pathogen reduction offer meaningful clinical and operational benefits, but their adoption depends on demonstrable interoperability, streamlined validation pathways, and strong post-sale support. Consumable quality and compatibility remain foundational to maintaining safety and workflow efficiency, making close collaboration between device manufacturers and consumable suppliers essential.

Regional and regulatory differences require tailored go-to-market approaches, with an emphasis on local service capabilities and evidence generation to support procurement decisions. Tariff environments and trade policy shifts add pressure to diversify sourcing and invest in regional manufacturing or assembly where feasible. Ultimately, the market rewards providers who deliver predictable outcomes, reduce complexity for clinical teams, and provide transparent total lifecycle value. Stakeholders that prioritize these imperatives will be better positioned to meet evolving clinical demands while navigating economic and policy headwinds.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Processing Devices & Consumables Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Anticoagulants And Additives
    • 8.1.2. Blood Bags And Sets
    • 8.1.3. Filters
    • 8.1.4. Test Kits
  • 8.2. Devices
    • 8.2.1. Apheresis Machines
    • 8.2.2. Centrifuges
    • 8.2.3. Pathogen Reduction Systems
    • 8.2.4. Storage Equipment

9. Blood Processing Devices & Consumables Market, by Technology

  • 9.1. Automated Processing
    • 9.1.1. Fully Automated Systems
    • 9.1.2. Semi Automated Systems
  • 9.2. Manual Processing

10. Blood Processing Devices & Consumables Market, by Application

  • 10.1. Blood Collection
  • 10.2. Component Separation
  • 10.3. Diagnostic Testing
  • 10.4. Pathogen Reduction
  • 10.5. Storage And Transportation

11. Blood Processing Devices & Consumables Market, by End User

  • 11.1. Blood Banks
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals And Clinics
  • 11.4. Research Institutes

12. Blood Processing Devices & Consumables Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. E Commerce

13. Blood Processing Devices & Consumables Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Blood Processing Devices & Consumables Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Blood Processing Devices & Consumables Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Blood Processing Devices & Consumables Market

17. China Blood Processing Devices & Consumables Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Baxter International
  • 18.7. Becton, Dickinson and Company
  • 18.8. Bio-Rad Laboratories, Inc.
  • 18.9. bioMerieux SA
  • 18.10. Danaher Corporation
  • 18.11. F. Hoffmann-La Roche Ltd.
  • 18.12. Fresenius Kabi
  • 18.13. Grifols, S.A.
  • 18.14. Haemonetics Corporation
  • 18.15. Immucor, Inc.
  • 18.16. Macopharma SA
  • 18.17. Terumo Corporation
  • 18.18. Thermo Fisher Scientific Inc.
  • 18.19. ThermoGenesis Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 174. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 175. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 177. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 201. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 202. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 204. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 210. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 211. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 213. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)